[Allergies to dental materials and effectiveness of treatment in the north-eastern region of Hungary].
The recognition and treatment of allergy is a great challenge for all fields of medicine. The high prevalence of allergic reactions to dental materials and the related financial burden of their treatment make investigation of this disease very important. Our investigation was carried out on patients assigned to our outpatient department for dental allergy test between 1996 and 1998. We determined the distribution of gender and age among the allergic patients in the examined population. We also studied the prevalence of allergic reactions to different dental allergens and the distribution of dental allergens. In a follow-up study we determined the proportion of those patients, who were retreated in conformity with the results of epicutan tests and we followed up the positive effects of these treatments. We have found that dental allergy occurred five times more frequently in women (84%) than in men (16%) and the most affected age group was between 20 to 39 and 40-49 years (31%). Seventy-five percent of the patients suffered from a combination of metal and polymer allergy. The most frequent metal allergen was TEGDMA (triethylene glycol dimethacrylate) (49.7%). The suggested treatment plan was carried out in 63% of the allergic patients. The applied treatment was successful in 48% of these cases. We experienced that 48% of these patients got rid of their earlier signs and symptoms.
Márta
M
Szepesi
Tünder
T
Radics
Géza
G
Vitályos
Csaba
C
Hegedűs
D000328:Adult; D017677:Age Distribution; D000368:Aged; D000485:Allergens / Q000009:adverse effects* / Q000276:immunology; D002712:Chlorides / Q000009:adverse effects; D003035:Cobalt / Q000009:adverse effects; D019327:Copper Sulfate / Q000009:adverse effects; D003764:Dental Materials / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D017612:Gold Compounds / Q000009:adverse effects; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D006967:Hypersensitivity / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D015994:Incidence; D008297:Male; D008670:Metals / Q000009:adverse effects* / Q000276:immunology; D008875:Middle Aged; D009532:Nickel / Q000009:adverse effects; D010045:Outpatients; D010165:Palladium / Q000009:adverse effects; D017671:Platinum Compounds / Q000009:adverse effects; D011092:Polyethylene Glycols / Q000009:adverse effects; D011108:Polymers / Q000009:adverse effects*; D011109:Polymethacrylic Acids / Q000009:adverse effects; D011192:Potassium Dichromate / Q000009:adverse effects; D017678:Sex Distribution; D018030:Silver Compounds / Q000009:adverse effects
D000485:Allergens; D002712:Chlorides; D003764:Dental Materials; D017612:Gold Compounds; D008670:Metals; D017671:Platinum Compounds; D011108:Polymers; D011109:Polymethacrylic Acids; D018030:Silver Compounds; C030173:platinum chloride; C020946:triethylene glycol dimethacrylate; D003035:Cobalt; D011092:Polyethylene Glycols; C029938:nickel sulfate; D010165:Palladium; D009532:Nickel; C024568:gold tetrachloride, acid; C026305:cobalt sulfate; D019327:Copper Sulfate; C008756:palladium chloride; D011192:Potassium Dichromate